{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-032780","form_type":"8-K","ticker":null,"cik":"0001815849","company_name":"ATI Physical Therapy, Inc.","filed_at":"2023-07-03T23:59:59+00:00","discovered_at":"2026-05-14T18:03:35.386284+00:00","generated_at":"2026-06-13T13:22:29.924518+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ATI Physical Therapy receives NYSE delisting notice for market cap and equity below $50M thresholds","bullets":["NYSE notified ATIP on June 28, 2023 that 30-day avg market cap was ~$41M and stockholders' equity was ~$20.5M as of March 31, 2023, both below $50M.","Company must submit a business plan within 45 days to NYSE; if accepted, it has 18 months to regain compliance.","Shares will trade with '.BC' designation and remain listed during cure period, subject to NYSE approval of plan.","ATIP also still non-compliant with $1.00 average price standard from Nov 2022; believes reverse stock split effective June 15, 2023 addresses that."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-032780","json":"https://secwatch.observer/filing/0001140361-23-032780.json","markdown":"https://secwatch.observer/filing/0001140361-23-032780.md","text":"https://secwatch.observer/filing/0001140361-23-032780.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1815849/000114036123032780/0001140361-23-032780-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1815849/000114036123032780/brhc20055261_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T13:22:29.924518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2eb1686351ee399d19635b4f01c2e8a259d45f22","claim":"ATI Physical Therapy, Inc. received a nyse deficiency notice notice regarding market value (rules 802.01B).","evidence_excerpt":"June 28, 2023 written notice, the NYSE advised the Company that it remains subject to the conditions set forth in the NYSE’s November 18, 2022 letter regarding noncompliance with the $1.00 over a 30 trading-day average price standard. The Company believes that it is in the process of regaining such compliance as a result of its previously announced reverse stock split effective June 15, 2023.","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1815849/000114036123032780/0001140361-23-032780-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nyse"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"market value"},{"label":"Rules","value":"802.01B"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}